Mylan hit with warning letter for valsartan manufacturing

The FDA sent a Mylan facility in India a warning letting for its manufacturing of APIs related to the widespread recall of blood pressure medications.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news